Khachaturov leaves “Rosgosstrakh” general director post to head directors board instead

YEREVAN, December 27. /ARKA/. Dmitry Markarov, first deputy director of “Rosgosstrakh” open joint stock company, the sole owner of Russia’s major insurer “Rosgosstrakh” LLC, has been appointed as general director.

Former general director of the company Danil Khachaturov who is considered to be the main owner of the company headed the board of directors of the OJSC, according to the report.

A five-year contract has been signed with Markarov who has no share in the authorized stock.

The day before Rosgosstrakh OJSC shares were leaders in trading amount at Moscow Stock Exchange. They were included on the A quoted list as from December 26
According to Moscow Stock Exchange, capitalization of Rosgosstrakh OJSC amounted to 133.9 billion rubles as of December 27.

The agency has not managed yet to get comments on change of the head of company, Novosti-Armenia reports referring to RIA Novosti.  –0–

spot_img

POPULAR

US dollar, euro, and ruble up against  Armenian dram

YEREVAN, August 20. /ARKA/. The average market exchange rate for the US dollar to the Armenian dram on the Armenian foreign exchange market as of August 20, 2026, increased by 0.3 points to 365.26 drams compared to August 19.

S&P affirms Armenia’s ratings, maintaining a positive outlook

The international rating agency S&P Global Ratings affirmed the long- and short-term sovereign ratings of the Republic of Armenia at 'BB-/B', maintaining a positive outlook, the Ministry of Finance reported.

Armenian dram strengthens against US dollar and weakens against euro and ruble

YEREVAN, August 21. /ARKA/. The average market exchange rate of the US dollar to the Armenian dram on the Armenian foreign exchange market on August 21, 2026, fell by 0.1 point to 365.16 drams compared to August 20.

Armenia set to enhance development of its capital market, targeting large issuers and new investors

YEREVAN, August 20. /ARKA/. The Armenian government prioritizes diversifying funding sources and advancing the capital market to foster sustainable and productive economic growth.

Shares of Noubar Afeyan’s Moderna soared 124% on news of a successful cancer vaccine trial

YEREVAN, August 20. /ARKA/. Shares of the biotech company Moderna soared 123.6% at the start of trading in the US on August 19, reaching a peak of $140.77, according to trading data. Shares of the pharmaceutical company Merck also rose 11.6% to $150.85, according to Forbes.ru.

LATEST NEWS

spot_imgspot_imgspot_img